644 related articles for article (PubMed ID: 33303218)
1. COVID-19 and diabetes: A bidirectional relationship.
Lima-Martínez MM; Carrera Boada C; Madera-Silva MD; Marín W; Contreras M
Clin Investig Arterioscler; 2021; 33(3):151-157. PubMed ID: 33303218
[TBL] [Abstract][Full Text] [Related]
2. Impaired Fasting Glucose and Diabetes Are Related to Higher Risks of Complications and Mortality Among Patients With Coronavirus Disease 2019.
Zhang J; Kong W; Xia P; Xu Y; Li L; Li Q; Yang L; Wei Q; Wang H; Li H; Zheng J; Sun H; Xia W; Liu G; Zhong X; Qiu K; Li Y; Wang H; Wang Y; Song X; Liu H; Xiong S; Liu Y; Cui Z; Hu Y; Chen L; Pan A; Zeng T
Front Endocrinol (Lausanne); 2020; 11():525. PubMed ID: 32754119
[No Abstract] [Full Text] [Related]
3. Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration.
Fadini GP; Morieri ML; Boscari F; Fioretto P; Maran A; Busetto L; Bonora BM; Selmin E; Arcidiacono G; Pinelli S; Farnia F; Falaguasta D; Russo L; Voltan G; Mazzocut S; Costantini G; Ghirardini F; Tresso S; Cattelan AM; Vianello A; Avogaro A; Vettor R
Diabetes Res Clin Pract; 2020 Oct; 168():108374. PubMed ID: 32805345
[TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19.
Singh AK; Singh R
Diabetes Res Clin Pract; 2020 Sep; 167():108382. PubMed ID: 32853686
[TBL] [Abstract][Full Text] [Related]
5. An overview of COVID-19 in people with diabetes: Pathophysiology and considerations in the inpatient setting.
Fleming N; Sacks LJ; Pham CT; Neoh SL; Ekinci EI
Diabet Med; 2021 Mar; 38(3):e14509. PubMed ID: 33377213
[TBL] [Abstract][Full Text] [Related]
6. Diabetes in the COVID-19 pandemic era.
Bonansea TCP; Santos LPD; Zintl K; Souza ACDS
Rev Assoc Med Bras (1992); 2021; 67Suppl 1(Suppl 1):157-162. PubMed ID: 34406303
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course.
Landstra CP; de Koning EJP
Front Endocrinol (Lausanne); 2021; 12():649525. PubMed ID: 34220706
[TBL] [Abstract][Full Text] [Related]
8. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
Jornayvaz FR; Assouline B; Pugin J; Gariani K
BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia and Angiotensin-Converting Enzyme 2 in Pulmonary Function in the Context of SARS-CoV-2 Infection.
Vargas-Rodriguez JR; Garza-Veloz I; Flores-Morales V; Badillo-Almaraz JI; Rocha-Pizaña MR; Valdés-Aguayo JJ; Martinez-Fierro ML
Front Med (Lausanne); 2021; 8():758414. PubMed ID: 35096863
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and diabetes-Two giants colliding: From pathophysiology to management.
Pelle MC; Zaffina I; Provenzano M; Moirano G; Arturi F
Front Endocrinol (Lausanne); 2022; 13():974540. PubMed ID: 36060943
[TBL] [Abstract][Full Text] [Related]
11. Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study.
Coppelli A; Giannarelli R; Aragona M; Penno G; Falcone M; Tiseo G; Ghiadoni L; Barbieri G; Monzani F; Virdis A; Menichetti F; Del Prato S;
Diabetes Care; 2020 Oct; 43(10):2345-2348. PubMed ID: 32788285
[TBL] [Abstract][Full Text] [Related]
12. Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients.
Ilias I; Jahaj E; Kokkoris S; Zervakis D; Temperikidis P; Magira E; Pratikaki M; Vassiliou AG; Routsi C; Kotanidou A; Dimopoulou I
In Vivo; 2020; 34(5):3029-3032. PubMed ID: 32871848
[TBL] [Abstract][Full Text] [Related]
13. Diabetes and COVID-19; A Bidirectional Interplay.
Kazakou P; Lambadiari V; Ikonomidis I; Kountouri A; Panagopoulos G; Athanasopoulos S; Korompoki E; Kalomenidis I; Dimopoulos MA; Mitrakou A
Front Endocrinol (Lausanne); 2022; 13():780663. PubMed ID: 35250853
[TBL] [Abstract][Full Text] [Related]
14. Clinical Trials of COVID-19 Therapies Should Account for Diabetes and Hyperglycemia.
Klonoff DC; Messler J; Valk T; Jagannathan R; Pasquel FJ; Umpierrez GE
J Diabetes Sci Technol; 2021 Sep; 15(5):1181-1187. PubMed ID: 34159841
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and outcomes of coronavirus disease 2019 infections among diabetics: A retrospective and multicenter study in China.
Yi H; Lu F; Jin X; Chen R; Liu B; Dong X; Xiong W; Yang D; Guo Y; Zhou M
J Diabetes; 2020 Dec; 12(12):919-928. PubMed ID: 32725691
[TBL] [Abstract][Full Text] [Related]
16. Glucovigilance in COVID-19.
Lamptey R; Ahomagnon S; Acheampong F; Kalra S
J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S80-S82. PubMed ID: 32515386
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 and diabetes: What do we know so far?
Gangadaran P; Padinjarathil H; Rajendran SHS; Jogalekar MP; Hong CM; Aruchamy B; Rajendran UM; Gurunagarajan S; Krishnan A; Ramani P; Subramanian K
Exp Biol Med (Maywood); 2022 Aug; 247(15):1330-1334. PubMed ID: 35894117
[TBL] [Abstract][Full Text] [Related]
18. COVID-19, Hyperglycemia, and New-Onset Diabetes.
Khunti K; Del Prato S; Mathieu C; Kahn SE; Gabbay RA; Buse JB
Diabetes Care; 2021 Dec; 44(12):2645-2655. PubMed ID: 34625431
[TBL] [Abstract][Full Text] [Related]
19. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Deranged Glucose Metabolism and Diabetes in the Pathogenesis and Prognosis of the Novel SARS-CoV-2: A Systematic Review of Literature.
Ukwenya VO; Adelakun SA; Fuwape TA; Adeagbo AS
Curr Diabetes Rev; 2022; 18(3):e060821195355. PubMed ID: 34365925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
